Stone House Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stone House Investment Management's AMGN Position: Q2 2026 in Review
Stone House Investment Management increased its Amgen (AMGN) stake by 0.39% in Q2 2026, buying an estimated $342 and bringing the position to 258 shares worth $93.5K. The position accounts for 0.01% of the portfolio, ranked #161.
Stone House Investment Management first reported a position in AMGN in Q1 2019 and has held it in 14 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Stone House Investment Management held 258 shares of Amgen worth $93.5K as of Q2 2026.
- Stone House Investment Management bought 1 Amgen share in Q2 2026, an estimated $342.
- Amgen made up 0.01% of Stone House Investment Management's portfolio in Q2 2026, its #161 holding.
- Stone House Investment Management first reported a position in Amgen in Q1 2019 and has held it in 14 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.